MicroRNAs in gastric cancer metastasis

Zhaoqi Shi1, Qingxia Wei2, Junjun She1

  • 1Department of General Surgery, 1st Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, 710061, Shaan'xi Province, China.

Insights

This review clarifies the role of microRNAs (miRNAs) in gastric cancer (GC) metastasis, highlighting their involvement in key steps like epithelial-mesenchymal transitions and invasion. Understanding these molecular mechanisms can improve GC prognosis and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer (GC) is a prevalent malignancy with a high propensity for metastasis.
  • The molecular underpinnings of GC metastasis remain incompletely understood.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in tumor progression.

Purpose of the Study:

  • To review the multifaceted roles of miRNAs in various stages of gastric cancer metastasis.
  • To elucidate the involvement of miRNAs in epithelial-mesenchymal transitions, anoikis, angiogenesis, invasion, and migration in GC.
  • To discuss the potential of miRNAs as prognostic biomarkers for gastric cancer.

Main Methods:

  • Comprehensive literature review of studies investigating miRNA involvement in GC metastasis.
  • Analysis of miRNA-mediated regulatory networks in key metastatic processes.
  • Synthesis of current evidence on clinical applications of miRNAs in GC.

Main Results:

  • miRNAs significantly influence multiple steps of GC metastasis, including EMT, anoikis, angiogenesis, invasion, and migration.
  • Specific miRNAs have been identified as either promoters or suppressors of GC metastasis.
  • miRNAs demonstrate potential as reliable prognostic biomarkers for GC patients.

Conclusions:

  • MicroRNAs play critical roles in the complex process of gastric cancer metastasis.
  • Targeting specific miRNAs may offer novel therapeutic strategies for GC.
  • Further research into miRNA functions and clinical utility is warranted for improved GC management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K